ICON PLC Operating Income Over Time
| ICLR Stock | USD 96.47 7.85 8.86% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ICON PLC Performance and ICON PLC Correlation. Can Life Sciences Tools & Services industry sustain growth momentum? Does ICON have expansion opportunities? Factors like these will boost the valuation of ICON PLC. Market participants price ICON higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating ICON PLC demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.99) | Earnings Share 7.42 | Revenue Per Share | Quarterly Revenue Growth 0.006 | Return On Assets |
The market value of ICON PLC is measured differently than its book value, which is the value of ICON that is recorded on the company's balance sheet. Investors also form their own opinion of ICON PLC's value that differs from its market value or its book value, called intrinsic value, which is ICON PLC's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because ICON PLC's market value can be influenced by many factors that don't directly affect ICON PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICON PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICON PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, ICON PLC's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare ICON PLC and related stocks such as EXACT Sciences, Guardant Health, and Medpace Holdings Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EXAS | (4 M) | (28.8 M) | (52.6 M) | (46.8 M) | (100.5 M) | (159.1 M) | (169 M) | (118.3 M) | (159.5 M) | (233.8 M) | (767.7 M) | (855.7 M) | (593.5 M) | (215 M) | (1 B) | (99.1 M) | (104 M) |
| GH | (43.8 M) | (43.8 M) | (43.8 M) | (43.8 M) | (43.8 M) | (43.8 M) | (43.8 M) | (76.6 M) | (92.9 M) | (82.4 M) | (254.9 M) | (411 M) | (544.4 M) | (564.7 M) | (443.6 M) | (399.2 M) | (419.2 M) |
| MEDP | 58.9 M | 58.9 M | 58.9 M | 58.9 M | 26 M | 20.6 M | 52.5 M | 64.9 M | 101 M | 127.3 M | 167 M | 198.6 M | 278.7 M | 336.8 M | 446.9 M | 534.9 M | 561.7 M |
| QGEN | 4.7 M | 99.6 M | 169.8 M | 63.3 M | 161.7 M | 179.5 M | 98.8 M | 153.4 M | 266.6 M | (26.1 M) | 386.4 M | 630.1 M | 531.5 M | 409.9 M | 97.7 M | 520.3 M | 546.3 M |
| UHS | 67.9 M | 897.1 M | 942.6 M | 1 B | 1.1 B | 1.3 B | 1.3 B | 1.3 B | 1.2 B | 1.2 B | 1.4 B | 1.4 B | 1 B | 1.2 B | 1.7 B | 1.9 B | 2 B |
| RVTY | 63.9 M | 117.9 M | 200.8 M | 258.8 M | 230.5 M | 266.8 M | 305.7 M | 304.6 M | 371 M | 405.5 M | 1 B | 1.3 B | 781.1 M | 399.5 M | 410.5 M | 356.6 M | 268.7 M |
| COO | 50.4 M | 283.4 M | 305.9 M | 306.5 M | 236.7 M | 324.1 M | 429.1 M | 403.1 M | 546.7 M | 311.8 M | 505.8 M | 507.6 M | 533.1 M | 705.7 M | 682.9 M | 785.3 M | 824.6 M |
| EHC | (1.7 M) | 374.1 M | 413.4 M | 458.8 M | 465.7 M | 554.2 M | 648.8 M | 649.4 M | 681.6 M | 692.5 M | 661.9 M | 659.4 M | 630.2 M | 1.7 B | 864.5 M | 760.1 M | 696.8 M |
| NBIX | 2.9 M | 33.9 M | 1.4 M | (49.7 M) | (64.4 M) | (94.2 M) | (147.4 M) | (131.4 M) | 36.9 M | 72.3 M | 163 M | 102.5 M | 249 M | 250.9 M | 570.5 M | 619.1 M | 650.1 M |
| SOLV | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.9 B | 1.7 B | 1.7 B | 1 B | 932.4 M | 1.2 B |
ICON PLC and related stocks such as EXACT Sciences, Guardant Health, and Medpace Holdings Operating Income description
Operating Income is the amount of profit realized from ICON PLC operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of ICON PLC is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| ICON PLC | ICLR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | South County Business |
| Exchange | NASDAQ Exchange |
USD 96.47
Additional Tools for ICON Stock Analysis
When running ICON PLC's price analysis, check to measure ICON PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICON PLC is operating at the current time. Most of ICON PLC's value examination focuses on studying past and present price action to predict the probability of ICON PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICON PLC's price. Additionally, you may evaluate how the addition of ICON PLC to your portfolios can decrease your overall portfolio volatility.